Can systemic inflammation raise D-dimer by triggering immunothrombosis without a classic clot?

The concept of immunothrombosis describes a physiological cross-talk between the innate immune system and the coagulation cascade, where systemic inflammation directly initiates blood clotting mechanisms. This process is increasingly recognized as a key driver of microvascular dysfunction in states of chronic or acute immune activation.

Mechanisms of cellular activation

Innate immune cells, specifically neutrophils and monocytes, are the primary drivers of this prothrombotic state.

• Monocyte involvement: When activated by inflammatory stimuli, monocytes upregulate the expression of Tissue Factor (TF). This protein is the primary initiator of the extrinsic coagulation pathway, leading to the rapid generation of thrombin and subsequent fibrin formation.
• Neutrophil extracellular traps (NETs): Neutrophils contribute by releasing NETs—scaffolds of DNA and histones. These structures provide a physical platform for platelet aggregation and activate Factor XII, the starting point of the intrinsic coagulation pathway. Furthermore, enzymes within NETs, such as elastase, can degrade natural anticoagulants like Tissue Factor Pathway Inhibitor (TFPI), further accelerating the clotting process.

Elevation of D-dimer without macrovascular clots

A critical clinical finding is that immunothrombosis can significantly raise D-dimer levels even when diagnostic imaging fails to find a "classic" macro-clot (such as a deep vein thrombosis or pulmonary embolism).

• Microvascular fibrin turnover: D-dimer is a byproduct of fibrin degradation. In immunothrombosis, fibrin is deposited and subsequently broken down on a microscopic scale within the capillaries.
• Clinical observations: Research in systemic inflammatory conditions has shown that D-dimer levels often correlate more closely with markers of inflammation (like C-reactive protein) than with the presence of large, detectable clots. For instance, in severe inflammatory states like COVID-19 or vasculitis, patients frequently present with highly elevated D-dimers (often exceeding 2000 ng/mL) despite negative imaging for traditional thrombosis.

Bottom line

Systemic inflammation triggers immunothrombosis through the activation of neutrophils and monocytes, leading to widespread microvascular fibrin formation. This process reliably elevates D-dimer levels, reflecting active immune-driven coagulation even in the absence of a traditional, large-scale blood clot.